Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated

References

• BousquetJKhaltaevNCruzAAAllergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)Allergy200863Suppl 86816018331513
   PubMed Web of Science ®Google Scholar
• CanonicaGWBousquetJMullolJScaddingGKVirchowJCA survey of the burden of allergic rhinitis in EuropeAllergy200762Suppl 85172517927674
   PubMed Web of Science ®Google Scholar
• EmanuelMBHay fever, a post industrial revolution epidemic: a history of its growth during the 19th centuryClin Allergy1988182953043293845
   PubMedGoogle Scholar
• StrachanDPEpidemiology of hay fever: towards a community diagnosisClin Exp Allergy1995252963037600374
   PubMed Web of Science ®Google Scholar
• von MutiusEWeilandSKFritzschCDuhmeHKeilUIncreasing prevalence of hay fever and atopy among children in Leipzig, East GermanyLancet19983518628669525363
   PubMed Web of Science ®Google Scholar
• BousquetPJChinnSJansonCKogevinasMBurneyPJarvisDGeographical variation in the prevalence of positive skin tests to environmental aeroallergens in the European Community Respiratory Health Survey IAllergy20076230130917298348
   PubMed Web of Science ®Google Scholar
• ScaddingGKKariyawasamHHAirways disease: just nosing around?Thorax20096492392519864539
   PubMed Web of Science ®Google Scholar
• ScaddingGKDurhamSRMirakianRBSACI guidelines for the management of allergic and non – allergic rhinitisClin Exp Allergy200838194218081563
   PubMed Web of Science ®Google Scholar
• RondonCFernandezJLopezSNasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitisJ Allergy Clin Immunol20091241005101119796796
   PubMed Web of Science ®Google Scholar
• CiprandiGCirilloIVizzaccaroAToscaMPassalacquaGPallestriniESeasonal and perennial allergic rhinitis: is this classification adherent to real life?Allergy20056088288715932377
   PubMed Web of Science ®Google Scholar
• NaclerioRMPintoJdeTineoMBaroodyFMElucidating the mechanism underlying the ocular symptoms associated with allergic rhinitisAllergy Asthma Proc200829242818302834
   PubMed Web of Science ®Google Scholar
• PortnoyJMVan OsdolTWilliamsPBEvidence-based strategies for treatment of allergic rhinitisCurr Allergy Asthma Rep2004443944615462709
   PubMed Web of Science ®Google Scholar
• WeinerJMAbramsonMJPuyRMIntranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trialsBMJ1998317162416299848901
   PubMed Web of Science ®Google Scholar
• YanezARodrigoGJIntranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysisAnn Allergy Asthma Immunol20028947948412452206
   PubMed Web of Science ®Google Scholar
• WilsonAMO’ByrnePMParameswaranKLeukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysisAm J Med200411633834414984820
   PubMed Web of Science ®Google Scholar
• DykewiczMSFinemanSSkonerDPDiagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and ImmunologyAnn Allergy Asthma Immunol1998814785189860027
   PubMed Web of Science ®Google Scholar
• WallaceDVDykewiczMSBernsteinDIThe diagnosis and management of rhinitis: an updated practice parameterJ Allergy Clin Immunol2008122S1S8418662584
   PubMed Web of Science ®Google Scholar
• LeynaertBNeukirchCKonySAssociation between asthma and rhinitis according to atopic sensitization in a population-based studyJ Allergy Clin Immunol2004113869314713912
   PubMed Web of Science ®Google Scholar
• MadoniniEBriatico-VangosaGPappacodaAMaccagniGCardaniASaporitiFSeasonal increase of bronchial reactivity in allergic rhinitisJ Allergy Clin Immunol1987793583633819219
   PubMed Web of Science ®Google Scholar
• CorrenJAdinoffADBuchmeierADIrvinCGNasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthmaJ Allergy Clin Immunol1992902502561500629
   PubMed Web of Science ®Google Scholar
• AubierMLevyJClericiCNeukirchFHermanDDifferent effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitisAm Rev Respir Dis19921461221261626795
   PubMed Web of Science ®Google Scholar
• StelmachRdo PatrocinioTNRibeiroMCukierAEffect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthmaChest20051283140314716304254
   PubMed Web of Science ®Google Scholar
• MurrayJRThe history of corticosteroidsActa DermVenereol Suppl (Stockh)198915146
   Google Scholar
• HenchPSKendallECThe effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritisMayo Clin Proc19492418119718118071
   PubMed Web of Science ®Google Scholar
• KatzMGansEHTopical corticosteroids, structure-activity and the glucocorticoid receptor: discovery and development – a process of “planned serendipity”J Pharm Sci2008972936294717975808
   PubMed Web of Science ®Google Scholar
• BrownHMStoreyGGeorgeWHBeclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthmaBr Med J197215855904335298
   PubMed Web of Science ®Google Scholar
• MygindNLocal effect of intranasal beclomethasone dipropionate aerosol in hay feverBr Med J197344644664586044
   PubMed Web of Science ®Google Scholar
• TurkeltaubPCNormanPSCrepeaSTreatment of ragweed hay fever with an intranasal spray containing fluinsolide, a new synthetic corticosteroidJ Allergy Clin Immunol197658597606789436
   PubMed Web of Science ®Google Scholar
• BalleVHPedersenUEngbyBAllergic perennial and non-allergic, vasomotor rhinitis treated with budesonide nasal sprayRhinology1980181351426997974
   PubMedGoogle Scholar
• MeltzerEOOrgelHABronskyEAA dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytologyJ Allergy Clin Immunol1990862212302200821
   PubMed Web of Science ®Google Scholar
• FindlaySHuberFGarciaJHuangLEfficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitisAnn Allergy1992682282321546817
   PubMedGoogle Scholar
• SchmidtBMTimmerWGeorgensACThe new topical steroid ciclesonide is effective in the treatment of allergic rhinitisJ Clin Pharmacol1999391062106910516941
   PubMed Web of Science ®Google Scholar
• HebertJRNolopKLutskyBNOnce-daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: an active- and placebo-controlled studyAllergy1996515695768874661
   PubMed Web of Science ®Google Scholar
• BikowskiJPillaiRShrootBThe position not the presence of the halogen in corticosteroids influences potency and side effectsJ Drugs Dermatol2006512513016485880
   PubMedGoogle Scholar
• PopperTLGentlesMJKungTTStructure-activity relationships of a series of novel topical corticosteroidsJ Steroid Biochem1987278378433695507
   PubMedGoogle Scholar
• PhillippsGHBaileyEJBainBMSynthesis and structure-activity relationships in a series of antiinflammatory corticosteroid analogues, halomethyl androstane-17 beta-carbothioates and -17 beta-carboselenoatesJ Med Chem199437371737297966132
   PubMed Web of Science ®Google Scholar
• DahlbergEThalenABrattsandRCorrelation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoidsMol Pharmacol19842570786708937
   PubMed Web of Science ®Google Scholar
• BuchwaldPGlucocorticoid receptor binding: a biphasic dependence on molecular size as revealed by the bilinear LinBiExp modelSteroids20087319320818022656
   PubMed Web of Science ®Google Scholar
• PujolsaLMullolJPicadoCGlucocorticoid receptor in human respiratory epithelial cellsNeuroimmunomodulation20091629029919571590
   PubMed Web of Science ®Google Scholar
• BrysonHMFauldsDIntranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitisDrugs1992437607751379151
   PubMed Web of Science ®Google Scholar
• HoggerPRohdewaldPBinding kinetics of fluticasone propionate to the human glucocorticoid receptorSteroids1994595976027878687
   PubMed Web of Science ®Google Scholar
• ValotisAHoggerPHuman receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoateRespir Res200785417650349
   PubMed Web of Science ®Google Scholar
• Daley-YatesPTBakerRCSystemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulationsBr J Clin Pharmacol20015110310511167672
   PubMed Web of Science ®Google Scholar
• FalcozCOliverRMcDowallJEVentrescaPByeADaley-YatesPTBioavailability of orally administered micronised fluticasone propionateClin Pharmacokinet200039Suppl 191511140434
   PubMed Web of Science ®Google Scholar
• MackieAEVentrescaGPFullerRWByeAPharmacokinetics of intravenous fluticasone propionate in healthy subjectsBr J Clin Pharmacol1996415395428799519
   PubMed Web of Science ®Google Scholar
• PearceRELeederJSKearnsGLBiotransformation of fluticasone: in vitro characterizationDrug Metab Dispos2006341035104016565171
   PubMed Web of Science ®Google Scholar
• HardingSMThe human pharmacology of fluticasone propionateRespir Med199084Suppl A25292287792
   PubMed Web of Science ®Google Scholar
• LaForceCFDockhornRJFindlaySRFluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescentsJ Fam Pract1994381451528308505
   PubMed Web of Science ®Google Scholar
• DolovichJO’ConnorMStepnerNSmithASharmaRKDouble-blind comparison of intranasal fluticasone propionate, 200 micrograms, once daily with 200 micrograms twice daily in the treatment of patients with severe seasonal allergic rhinitis to ragweedAnn Allergy1994724354408179230
   PubMedGoogle Scholar
• PedersenBDahlRRichardsDHOnce daily fluticasone propionate aqueous nasal spray controls symptoms of most patients with seasonal allergic rhinitisAllergy199550794998607560
   PubMed Web of Science ®Google Scholar
• DykewiczMSKaiserHBNathanRAFluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn)Ann Allergy Asthma Immunol200391444812877448
   PubMed Web of Science ®Google Scholar
• MeltzerEORickardKAWestlundRECookCKOnset of therapeutic effect of fluticasone propionate aqueous nasal sprayAnn Allergy Asthma Immunol20018628629111289326
   PubMed Web of Science ®Google Scholar
• BonerASetteLMartinatiLSharmaRKRichardsDHThe efficacy and tolerability of fluticasone propionate aqueous nasal spray in children with seasonal allergic rhinitisAllergy1995504985057573843
   PubMed Web of Science ®Google Scholar
• GrossmanJBanovCBronskyEAFluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitisPediatrics1993925945998414833
   PubMed Web of Science ®Google Scholar
• MunkZMPearlmanDGraftDIntranasal fluticasone propionate is effective and well-tolerated in adolescents with seasonal allergic rhinitisPediatr Asthma Allergy Immunol199483946
   Google Scholar
• KeithPNieminenJHollingworthKDolovichJEfficacy and tolerability of fluticasone propionate nasal drops 400 microgram once daily compared with placebo for the treatment of bilateral polyposis in adultsClin Exp Allergy2000301460146810998024
   PubMed Web of Science ®Google Scholar
• SalterMBiggadikeKMatthewsJLPharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory diseaseAm J Physiol Lung Cell Mol Physiol2007293L660L66717575011
   PubMed Web of Science ®Google Scholar
• AllenADownGNewlandAAbsolute bioavailability of intranasal fluticasone furoate in healthy subjectsClin Ther2007291415142017825692
   PubMed Web of Science ®Google Scholar
• HughesSCShardlowPCHollisFJMetabolism and disposition of fluticasone furoate, an enhanced-affinity glucocorticoid, in humansDrug Metab Dispos2008362337234418694910
   PubMed Web of Science ®Google Scholar
• MartinBGRatnerPHHampelFCOptimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescentsAllergy Asthma Proc20072821622517479608
   PubMed Web of Science ®Google Scholar
• FokkensWJJogiRReinartzSOnce daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollenAllergy2007621078108417686111
   PubMed Web of Science ®Google Scholar
• KaiserHBNaclerioRMGivenJTolerTNEllsworthAPhilpotEEFluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitisJ Allergy Clin Immunol20071191430143717418384
   PubMed Web of Science ®Google Scholar
• JacobsRMartinBHampelFTolerWEllsworthAPhilpotEEffectiveness of fluticasone furoate 110 mug once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollenCurr Med Res Opin2009251393140119419338
   PubMed Web of Science ®Google Scholar
• KeithPKScaddingGKAre intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?Curr Med Res Opin2009252021204119569975
   PubMed Web of Science ®Google Scholar
• BaroodyFMShenaqDdeTineoMWangJNaclerioRMFluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptomsJ Allergy Clin Immunol20091231342134819428097
   PubMed Web of Science ®Google Scholar
• BaumannDBachertCHoggerPDissolution in nasal fluid, retention and anti-inflammatory activity of fluticasone furoate in human nasal tissue ex vivoClin Exp Allergy2009391540155019538495
   PubMed Web of Science ®Google Scholar
• RaapUBraunstahlGJThe role of neurotrophins in the pathophysiology of allergic rhinitisCurr Opin Allergy Clin Immunol20101081319935061
   PubMed Web of Science ®Google Scholar
• MeltzerEOLeeJTripathyILimJEllsworthAPhilpotEEfficacy and safety of once-daily fluticasone furoate nasal spray in children with seasonal allergic rhinitis treated for 2 weeksPediatr Allergy Immunol20092027928618680490
   PubMed Web of Science ®Google Scholar
• SkonerJDSchaffnerTJSchadCAKwonAYSkonerDPAddressing steroid phobia: improving the risk-benefit ratio with new agentsAllergy Asthma Proc20082935836418702881
   PubMed Web of Science ®Google Scholar
• BruniFMDe LucaGVenturoliVBonerALIntranasal corticosteroids and adrenal suppressionNeuro immuno modulation200916353362
   PubMed Web of Science ®Google Scholar
• van AsABronskyEGrossmanJMeltzerERatnerPReedCDose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitisAnn Allergy1991671561621867454
   PubMedGoogle Scholar
• VargasRDockhornRJFindlaySRKorenblatPEFieldEAKralKMEffect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axisJ Allergy Clin Immunol19981021911979723660
   PubMed Web of Science ®Google Scholar
• HayeRGomezEGA multicentre study to assess long-term use of fluticasone propionate aqueous nasal spray in comparison with beclomethasone dipropionate aqueous nasal spray in the treatment of perennial rhinitisRhinology1993311691748140383
   PubMedGoogle Scholar
• HowlandWCIIIFluticasone propionate: topical or systemic effects?Clin Exp Allergy199626Suppl 318228735854
   PubMed Web of Science ®Google Scholar
• ScaddingGKLundVJHolmstromMDarbyYCClinical and physiological effects of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitisRhinol Suppl19911137431888556
   PubMedGoogle Scholar
• RichardsDHMiltonCMFluticasone propionate aqueous nasal spray: a well-tolerated and effective treatment for children with perennial rhinitisPediatr Allergy Immunol1996735438792382
   PubMed Web of Science ®Google Scholar
• Treatment of seasonal allergic rhinitis with once-daily intranasal fluticasone propionate therapy in childrenFluticasone Propionate Collaborative Pediatric Working GroupJ Pediatr19941256286347931889
   PubMed Web of Science ®Google Scholar
• RosenblutABardinPGMullerBLong-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitisAllergy2007621071107717686110
   PubMed Web of Science ®Google Scholar
• TripathyILevyARatnerPClementsDWuWPhilpotEHPA axis safety of fluticasone furoate nasal spray once daily in children with perennial allergic rhinitisPediatr Allergy Immunol20092028729419175889
   PubMed Web of Science ®Google Scholar
• MasperoJFRosenblutAFinnAJrLimJWuWPhilpotESafety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitisOtolaryngol Head Neck Surg2008138303718164990
   PubMed Web of Science ®Google Scholar
• MeltzerEOTripathyIMasperoJFWuWPhilpotESafety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6–11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studiesClin Drug Investig2009297986
   PubMed Web of Science ®Google Scholar
• GradmanJCaldwellMFWolthersODA 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitisClin Ther2007291738174717919555
   PubMed Web of Science ®Google Scholar
• KhannaPShahAAssessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitisAm J Rhinol20051931632116011141
   PubMedGoogle Scholar
• MahadeviaPJShahSLeibmanCKleinmanLO’DowdLPatient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysisAnn Allergy Asthma Immunol20049334535015521370
   PubMed Web of Science ®Google Scholar
• MeltzerEOBardelasJGoldsobelAKaiserHA preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitisTreat Respir Med2005428929616086602
   PubMedGoogle Scholar
• BousquetJVan CauwenbergePBachertCRequirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA)Allergy20035819219712653792
   PubMed Web of Science ®Google Scholar
• WaddellANPatelSKTomaAGMawARIntranasal steroid sprays in the treatment of rhinitis: is one better than another?J Laryngol Otol200311784384514670141
   PubMed Web of Science ®Google Scholar
• BaroodyFMChengCCMoylanBAbsence of nasal mucosal atrophy with fluticasone aqueous nasal sprayArch Otolaryngol Head Neck Surg200112719319911177038
   PubMed Web of Science ®Google Scholar
• StokesMAmorosiSLThompsonDDupclayLGarciaJGeorgesGEvaluation of patients’ preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitisOtolaryngol Head Neck Surg200413122523115365540
   PubMed Web of Science ®Google Scholar
• BachertCEl AkkadTPatient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitisAnn Allergy Asthma Immunol20028929229712269650
   PubMed Web of Science ®Google Scholar
• Daley-YatesPTRichardsDHRelationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic modelClin Ther2004261905191915639702
   PubMed Web of Science ®Google Scholar
• BergerWEGodfreyJWSlaterALIntranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved complianceExpert Opin Drug Deliv2007468970117970670
   PubMed Web of Science ®Google Scholar